INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION
发明人:
申请号：
EP10705949.5
公开号：
EP2395990B1
申请日:
2010.02.12
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
Subjects who were diagnosed with either comorbid or idiopathic autism were treated with acamprosate. Patients generally showed marked improvements in primary outcomes as assessed using, for example, standard clinic measures for functionality including the Clinical Global Impressions Improvement (CGI-I) and the Clinical Global Impressions Severity (CGI-S) scales.
